DGAP-Adhoc: QIAGEN N.V.: QIAGEN announces CEO leadership transition
DGAP-Ad-hoc: QIAGEN N.V. / Key word(s): Personnel
QIAGEN N.V.: QIAGEN announces CEO leadership transition
07-Oct-2019 / 22:04 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
English Version
Ad-hoc Announcement pursuant to Article 17 Market Abuse Regulation
QIAGEN announces CEO leadership transition
Venlo, The Netherlands, October 7, 2019 - QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announces that Peer M. Schatz, Chief Executive Officer, has notified the Company that he has decided to step down as Chief Executive Officer and Chairman of the Management Board. He will remain with QIAGEN as Advisor to the Supervisory Board and transition into this role in the coming weeks. The Supervisory Board will now start a search for a permanent CEO. In the meantime, Thierry Bernard, Senior Vice President, Head of Molecular Diagnostics Business Area, will now act as interim CEO and work in tandem with Roland Sackers, Chief Financial Officer.
QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
The Netherlands
ISIN: NL0012169213
Frankfurt Stock Exchange, regulated market (Prime Standard)
Contact
John Gilardi
Vice President, Head of Corporate Communications and Investor Relations
+49 2103 29 11711 and +1 240 686 2222
john.gilardi@qiagen.com
07-Oct-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
End of Announcement DGAP News Service
886527 07-Oct-2019 CET/CEST